DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

447.52 -9.90 (-2.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $447.52 -2.16%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $451.58
Previous Close $457.42
Daily Range $442.60 - $455.78
52-Week Range $269.50 - $495.50
Market Cap $45.9B
P/E Ratio 149.00
Dividend (Yield) $0.00 (0.0%)
Volume 675,956
Average Daily Volume 882,333
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

The 3 Best Stocks for Investing in Cholesterol Drugs

An aging population and rising prevalence of heart disease suggest that investing in the next generation of cholesterol drugs could prove to be profitable.

3 Potential Blockbuster Drugs That Could Be Approved Before Year's End

Our experts weigh in on some drug candidates with huge potential.

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Jim Cramer -- If You're Not in Biotech for the Long Haul, Hit the Road

Nasdaq 100 Movers: VIAB, REGN

Following Gilead Sciences, Inc., Which Biotech Will Pay a Dividend Next?

Our experts weigh in.

Biotech Bubble Valuations From Sam Islay

Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on Liver Disease Data - Analyst Blog

Stock Market News for April 01, 2015 - Market News

Ohr Pharmaceutical Crashes on Disappointing Eye Drug Data - Analyst Blog

See More REGN News...

REGN's Top Competitors

REGN $447.52 (-2.16%)
Current stock: REGN
GILD $101.38 (-1.90%)
Current stock: GILD
CELG $113.47 (-2.48%)
Current stock: CELG
AMGN $163.58 (-1.97%)
Current stock: AMGN